Bala et al. found that patients taking aspirin had the lowest incidence of deep vein thrombosis compared with those using other antiplatelet agents, including factor Xa inhibitors, enoxaparin, and warfarin (46). The gene discussed is F10; the disease is deep vein thrombosis.